Drug Information

Drug General Information
Drug ID
D0S3EM
Former ID
DNCL003358
Drug Name
CAZ AVI
Synonyms
CAZ104
Indication Serious infections [ICD9: 001-139; ICD10:A00-B99] Phase 3 [523980]
Company
AstraZeneca
Target and Pathway
Target(s) Beta-lactamase Target Info Modulator [531904]
References
Ref 523980ClinicalTrials.gov (NCT01644643) Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens. U.S. National Institutes of Health.
Ref 531904NXL104 irreversibly inhibits the beta-lactamase from Mycobacterium tuberculosis. Biochemistry. 2012 Jun 5;51(22):4551-7. Epub 2012 May 22.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.